"June 24, 2015 -- Researchers have been testing individual chemicals for years to see if they can cause cancer.
Now, a groundbreaking new report suggests scientists should also be looking at how low doses of chemicals considered safe on the"...
AdreView (iobenguane i 123 injection for intravenous use) is contraindicated in patients with known hypersensitivity to iobenguane or iobenguane sulfate.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/2/2009
Additional AdreView Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.